Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | Starlite/ChEMBL | References |
Homo sapiens | matrix metallopeptidase 1 (interstitial collagenase) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Matrixin family protein | matrix metallopeptidase 1 (interstitial collagenase) | 403 aa | 401 aa | 27.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | Aminopeptidase M1, putative | 0.0067 | 0.0016 | 0.5 |
Echinococcus multilocularis | aminopeptidase N | 0.0229 | 1 | 1 |
Leishmania major | aminopeptidase, putative,metallo-peptidase, Clan MA(E), Family M1 | 0.0067 | 0.0016 | 0.5 |
Brugia malayi | Peptidase family M1 containing protein | 0.0067 | 0.0016 | 0.0016 |
Leishmania major | aminopeptidase-like protein,metallo-peptidase, Clan MA(E), Family M1 | 0.0067 | 0.0016 | 0.5 |
Echinococcus granulosus | aminopeptidase N | 0.0229 | 1 | 1 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.0105 | 0.2341 | 0.2341 |
Brugia malayi | hypothetical protein | 0.0067 | 0.0016 | 0.0016 |
Onchocerca volvulus | Matrilysin homolog | 0.0105 | 0.2341 | 0.2341 |
Trypanosoma cruzi | aminopeptidase, putative | 0.0067 | 0.0016 | 0.5 |
Trypanosoma brucei | Aminopeptidase M1, putative | 0.0067 | 0.0016 | 0.5 |
Trypanosoma brucei | metallo-peptidase, Clan MA(E) Family M1 | 0.0067 | 0.0016 | 0.5 |
Loa Loa (eye worm) | peptidase family M1 containing protein | 0.0185 | 0.7299 | 0.8549 |
Trichomonas vaginalis | Clan MA, family M1, aminopeptidase N-like metallopeptidase | 0.0067 | 0.0016 | 0.5 |
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | 0.0172 | 0.649 | 0.6485 |
Trypanosoma cruzi | metallo-peptidase, clan MA(E), family M1, putative | 0.0067 | 0.0016 | 0.5 |
Trichomonas vaginalis | Clan MA, family M1, aminopeptidase N-like metallopeptidase | 0.0067 | 0.0016 | 0.5 |
Entamoeba histolytica | aminopeptidase, putative | 0.0067 | 0.0016 | 0.5 |
Schistosoma mansoni | aminopeptidase PILS (M01 family) | 0.0067 | 0.0016 | 1 |
Mycobacterium ulcerans | aminopeptidase N PepN | 0.0067 | 0.0016 | 0.5 |
Loa Loa (eye worm) | matrixin family protein | 0.0115 | 0.2926 | 0.3416 |
Loa Loa (eye worm) | matrixin family protein | 0.0105 | 0.2341 | 0.2729 |
Brugia malayi | Matrixin family protein | 0.0115 | 0.2926 | 0.2926 |
Schistosoma mansoni | cytosol alanyl aminopeptidase (M01 family) | 0.0067 | 0.0016 | 1 |
Onchocerca volvulus | 0.0067 | 0.0016 | 0.0016 | |
Trypanosoma brucei | Aminopeptidase M1, putative | 0.0067 | 0.0016 | 0.5 |
Onchocerca volvulus | 0.0229 | 1 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0162 | 0.5835 | 0.683 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.0172 | 0.649 | 0.6485 |
Loa Loa (eye worm) | hypothetical protein | 0.0205 | 0.8536 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 5.49 | Inhibition of MMP9 (unknown origin) | ChEMBL. | 17275314 |
IC50 (binding) | = 7.14 | Inhibition of MMP1 (unknown origin) | ChEMBL. | 17275314 |
IC50 (binding) | = 73 nM | Inhibitory activity against Matrix metalloproteinase-1 | ChEMBL. | 10212120 |
IC50 (binding) | = 73 nM | Inhibitory activity against Matrix metalloproteinase-1 | ChEMBL. | 10212120 |
IC50 (binding) | = 3200 nM | Inhibitory activity against Matrix metalloproteinase-9 | ChEMBL. | 10212120 |
IC50 (binding) | = 3200 nM | Inhibitory activity against Matrix metalloproteinase-9 | ChEMBL. | 10212120 |
log(1/IC50) (binding) | = 5.49 | Inhibition of MMP9 (unknown origin) | ChEMBL. | 17275314 |
log(1/IC50) (binding) | = 7.14 | Inhibition of MMP1 (unknown origin) | ChEMBL. | 17275314 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.